Search ALB
Albemarle Corporation
NYSE · CIK 915913
Last close104.59
Daily change-0.44 (-0.42%)
10 Years gain+41.13%
Dividends TTM1.63 (+0.31%)
Dividend yield1.55%
Fundamental Analysis
ALB · STANDARD
SIC 2821 · Plastic Materials, Synth Resins & Nonvulcan Elastomers · Fiscal year end 1231
Fundamental
33.7Momentum
100.0Acceleration
100.0Confidence
83.0Annual Revenue18
Quarterly Revenue75
Annual CFO18
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth4.3 / 25
Quality5.9 / 25
Capital Efficiency3.3 / 20
Balance Sheet12.7 / 15
Shareholder Economics2.6 / 10
Forward Indicators5.0 / 5
Signals
Gross margin expansionGross margin improved by 22.6522 percentage points.
Operating leverageOperating margin improved by 42.6203 percentage points.
ROIC expansionROIC improved by 15.2122 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Heavy share dilution · HIGHDiluted share count increased 15.8236%.
Key Metrics
Revenue Growth TTM11.24%OK
Revenue CAGR 3Y-11.1%OK
Gross Margin24.2%OK
Operating Margin8.9%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC3.62%OK
Incremental Operating Margin 3Y-11.34%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y15.82%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $5.14B | $668.72M | -$367.08M | $1.28B | $692.47M | 13% | -7.14% | 13.46% | -2.48% | 117.66M |
| 2025 FY Dec 31, 2024 | $5.38B | $62.54M | -$1.78B | $687.88M | -$992.65M | 1.16% | -33.04% | -18.46% | -11.24% | 117.52M |
| 2025 FY Dec 31, 2023 | $9.62B | $1.19B | $251.88M | $1.33B | -$827.96M | 12.33% | 2.62% | -8.61% | 1.67% | 117.77M |
| 2024 FY Dec 31, 2022 | $7.32B | $3.07B | $2.47B | n/a | n/a | 42% | 33.74% | n/a | 20.78% | 117.79M |
| 2023 FY Dec 31, 2021 | $3.33B | $997.97M | $798.43M | $344.26M | -$609.41M | 29.99% | 23.99% | -18.31% | 8.6% | 116.54M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $5.81B | sum latest 4 fiscal quarters Revenue | OK | 0000915913-26-000102, 0000915913-25-000162 |
| Revenue Growth TTM | 11.24% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000915913-26-000102, 0000915913-25-000162 |
| Revenue CAGR 3Y | -11.1% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000915913-26-000018 |
| Revenue CAGR 5Y | 10.45% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000915913-26-000018 |
| Gross Profit CAGR 3Y | -39.86% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000915913-26-000018 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0000915913-26-000102, 0000915913-25-000162 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 24.2% | Gross Profit / Revenue | OK | 0000915913-26-000102, 0000915913-25-000162 |
| Operating Margin | 8.9% | Operating Income / Revenue | OK | 0000915913-26-000102, 0000915913-25-000162 |
| ROIC | 3.62% | NOPAT / Average Invested Capital | OK | 0000915913-26-000102, 0000915913-25-000162 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000915913-26-000102 |
| Current Ratio | 2.09x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.87x | (Cash + Short-term Investments) / Total Debt | OK | 0000915913-26-000102 |
| Revenue per Diluted Share | $42.65 | Revenue / Diluted Shares | OK | 0000915913-26-000102, 0000915913-25-000162 |